MARKHAM, ON, April 16, 2018 /CNW/ - MedReleaf Corp.
(TSX:LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and
ICH-GMP certified cannabis producer, today announced the
introduction of Product Identification Numbers, or "PINs", for 57
of its unique medical cannabis products including dried flower,
oils and capsules. With this announcement, MedReleaf
continues to demonstrate leadership among Canadian licensed
producers to facilitate the coverage of medical cannabis on
employer-sponsored benefits plans.
Product Identification Numbers (PINs) are similar to traditional
Drug Identification Numbers (DINs), designed to make it easier for
employers and payers to classify and incorporate pharmaceutical and
health care products into benefits coverage plans.
"Medical cannabis is being covered by an ever-increasing number
of employers across Canada through
health spending accounts and extended health benefits plans, but
without an identification number for each product, it can be
difficult to incorporate and track the use of our products within
core health benefits programs," said Robert, Gora, Senior Director
of Physician Outreach. "Introducing PINs will help willing insurers
and employers to list MedReleaf's cannabis medicines on their
formularies, improving access and cannabis drug coverage for
patients across Canada."
"We have extensive experience in developing programs to support
large patient groups and we are encouraged by the growing interest
we are seeing from employers and payers in covering medical
cannabis products," noted Neil
Closner, CEO of MedReleaf. "Working with employers to update
workplace drug and alcohol policies, providing guidance on benefit
plan design, and now adding PINs to our industry-leading products,
are all proof points of our commitment to leadership, innovation
and education regarding the therapeutic benefits of cannabis."
About MedReleaf Corp.
Voted Top Licensed Producer at the 2017 Lift Canadian Cannabis
Awards, MedReleaf is an R&D-driven company dedicated
to innovation, operational excellence and the production of
top-quality cannabis. Sourced from around the world and
carefully cultivated in one of two state of the art ICH-GMP and ISO
90001 certified facilities in Ontario, the Company
delivers a variety of premium products for the global medical
market and is committed to serving the therapeutic needs of its
medical patients and providing a compelling product assortment for
the adult-use recreational consumer.
For more information on MedReleaf, its products, research
and how the company is helping patients #livefree, please visit
MedReleaf.com or follow @medreleaf
SOURCE MedReleaf Corp.